Mitigated tregs and augmented Th17 cells and cytokines are associated with severity of experimental autoimmune neuritis

Scandinavian Journal of Immunology

Volumn 80, Issue 3, 2014, Pages 180-190

  Wang, X ^a,b   Zheng, X Y ^a,b   Ma, C ^a   Wang, X K ^c   Wu, J ^a   Adem, A ^d   Zhu, J ^a,b   Zhang, H L ^a,b  

^a THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

^b KAROLINSKA INSTITUTE   (Sweden)

^c THE SECOND HOSPITAL OF JILIN UNIVERSITY   (China)

^d UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 12P70; INTERLEUKIN 17; INTERLEUKIN 17 RECEPTOR; INTERLEUKIN 17 RECEPTOR A; INTERLEUKIN 17 RECEPTOR C; INTERLEUKIN 22; INTERLEUKIN 6; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CAUDA EQUINA; CD4+ T LYMPHOCYTE; CELL INFILTRATION; CONTROLLED STUDY; DISEASE ASSOCIATION; EXPERIMENTAL AUTOIMMUNE NEURITIS; LYMPHOCYTE MIGRATION; MALE; MONONUCLEAR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; TH1 CELL; TH17 CELL; TH2 CELL;

ANIMALS; CAUDA EQUINA; CYTOKINES; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; GUILLAIN-BARRE SYNDROME; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-17; INTERLEUKIN-6; INTERLEUKINS; MALE; MICE, INBRED C57BL; NEURITIS, AUTOIMMUNE, EXPERIMENTAL; RECEPTORS, INTERLEUKIN-17; SEVERITY OF ILLNESS INDEX; SPLEEN; T-LYMPHOCYTES, REGULATORY; TH1 CELLS; TH17 CELLS; TH2 CELLS; TIME FACTORS;

EID: 84906251879     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/sji.12201     Document Type: Article

References (28)

1. van Doorn PA, Ruts L, Jacobs BC. Clinical features, pathogenesis, and treatment of Guillain-Barré syndrome. Lancet Neurol 2008;7:939-50.
2. Zhang HL, Hassan MY, Zheng XY et al. Attenuated EAN in TNF-alpha deficient mice is associated with an altered balance of M1/M2 macrophages. PLoS ONE 2012;7:e38157.
3. Zhu W, Mix E, Nennesmo I, Adem A, Zhu J. Anti-cytokine autoantibodies in experimental autoimmune neuritis in Lewis rats. Exp Neurol 2004;190:486-94.
4. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986;136:2348-57.
5. Nyati KK, Prasad KN, Rizwan A, Verma A, Paliwal VK. TH1 and TH2 response to Campylobacter jejuni antigen in Guillain-Barre syndrome. Arch Neurol 2011;68:445-52.
6. Zhang HL, Azimullah S, Zheng XY et al. IFN-gamma deficiency exacerbates experimental autoimmune neuritis in mice despite a mitigated systemic Th1 immune response. J Neuroimmunol 2012;246:18-26.
7. Harrington LE, Hatton RD, Mangan PR et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005;6:1123-32.
8. Li XL, Dou YC, Liu Y et al. Atorvastatin ameliorates experimental autoimmune neuritis by decreased Th1/Th17 cytokines and up-regulated T regulatory cells. Cell Immunol 2011;271:455-61.
9. Zhang ZY, Zhang Z, Schluesener HJ. FTY720 attenuates lesional interleukin-17 + cell accumulation in rat experimental autoimmune neuritis. Neuropathol Appl Neurobiol 2009;35:487-95.
10. Wang X, Ma C, Wu J, Zhu J. Roles of T helper 17 cells and interleukin-17 in neuroautoimmune diseases with emphasis on multiple sclerosis and Guillain-Barre syndrome as well as their animal models. J Neurosci Res 2013;91:871-81.
11. Liang SL, Wang WZ, Huang S, Wang XK, Zhang S, Wu Y. Th17 helper cell and T-cell immunoglobulin and mucin domain 3 involvement in Guillain-Barre syndrome. Immunopharmacol Immunotoxicol 2012;34:1039-46.
12. Li S, Yu M, Li H, Zhang H, Jiang Y. IL-17 and IL-22 in Cerebrospinal Fluid and Plasma Are Elevated in Guillain-Barre Syndrome. Mediators Inflamm 2012;2012:260473.
13. Duan RS, Chen Z, Bao L et al. CCR5 deficiency does not prevent P0 peptide 180-199 immunized mice from experimental autoimmune neuritis. Neurobiol Dis 2004;16:630-7.
14. Pelidou SH, Zou LP, Deretzi G, Oniding C, Mix E, Zhu J. Enhancement of acute phase and inhibition of chronic phase of experimental autoimmune neuritis in Lewis rats by intranasal administration of recombinant mouse interleukin 17: potential immunoregulatory role. Exp Neurol 2000;163:165-72.
15. Iwakura Y, Ishigame H, Saijo S, Nakae S. Functional specialization of interleukin-17 family members. Immunity 2011;34:149-62.
16. Korn T, Bettelli E, Oukka M, Kuchroo VK. IL-17 and Th17 Cells. Annu Rev Immunol 2009;27:485-517.
17. Hot A, Lenief V, Miossec P. Combination of IL-17 and TNFalpha induces a pro-inflammatory, pro-coagulant and pro-thrombotic phenotype in human endothelial cells. Ann Rheum Dis 2012;71:768-76.
18. Takaya H, Andoh A, Makino J et al. Interleukin-17 stimulates chemokine (interleukin-8 and monocyte chemoattractant protein-1) secretion in human pancreatic periacinar myofibroblasts. Scand J Gastroenterol 2002;37:239-45.
19. Zhang ZY, Zhang Z, Zug C, Nuesslein-Hildesheim B, Leppert D, Schluesener HJ. AUY954, a selective S1P(1) modulator, prevents experimental autoimmune neuritis. J Neuroimmunol 2009;216:59-65.
20. Zhou L, Lopes JE, Chong MM et al. TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature 2008;453:236-40.
21. Chen Y, Haines CJ, Gutcher I et al. Foxp3(+) regulatory T cells promote T helper 17 cell development in vivo through regulation of interleukin-2. Immunity 2011;34:409-21.
22. Pandiyan P, Conti HR, Zheng L et al. CD4(+)CD25(+)Foxp3(+) regulatory T cells promote Th17 cells in vitro and enhance host resistance in mouse Candida albicans Th17 cell infection model. Immunity 2011;34:422-34.
23. Matsushita T, Horikawa M, Iwata Y, Tedder TF. Regulatory B cells (B10 cells) and regulatory T cells have independent roles in controlling experimental autoimmune encephalomyelitis initiation and late-phase immunopathogenesis. J Immunol 2010;185:2240-52.
24. Barin JG, Baldeviano GC, Talor MV et al. Macrophages participate in IL-17-mediated inflammation. Eur J Immunol 2012;42:726-36.
25. Zhu J, Bai XF, Mix E, Link H. Cytokine dichotomy in peripheral nervous system influences the outcome of experimental allergic neuritis: dynamics of mRNA expression for IL-1 beta, IL-6, IL-10, IL-12, TNF-alpha, TNF-beta, and cytolysin. Clin Immunol Immunopathol 1997;84:85-94.
26. Press R, Ozenci V, Kouwenhoven M, Link H. Non-T(H)1 cytokines are augmented systematically early in Guillain-Barre syndrome. Neurology 2002;58:476-8.
27. Zhang HL, Zheng XY, Zhu J. Th1/Th2/Th17/Treg cytokines in Guillain-Barre syndrome and experimental autoimmune neuritis. Cytokine Growth Factor Rev 2013;24:443-53.
28. Peters A, Lee Y, Kuchroo VK. The many faces of Th17 cells. Curr Opin Immunol 2011;23:702-6.